Susquehanna International Group’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-150,813
Closed -$264K 13650
2025
Q1
$264K Buy
150,813
+114,625
+317% +$151K ﹤0.01% 10348
2024
Q4
$57.2K Buy
+36,188
New +$55.6K ﹤0.01% 11624
2024
Q3
Hold
0
13043
2024
Q2
Sell
-22,528
Closed -$52.3K 13226
2024
Q1
$64.9K Buy
+22,528
New +$36.7K ﹤0.01% 11445
2023
Q4
Hold
0
13277
2023
Q3
Hold
0
12973
2023
Q2
Hold
0
13107
2023
Q1
Hold
0
13480
2022
Q4
Hold
0
13640
2022
Q3
Hold
0
14138
2022
Q2
Sell
-6,583
Closed -$16K 13982
2022
Q1
$20K Buy
+6,583
New +$17.1K ﹤0.01% 12622
2021
Q4
Sell
-16,416
Closed -$73K 13968
2021
Q3
$113K Buy
16,416
+3,887
+31% +$28.5K ﹤0.01% 11987
2021
Q2
$102K Buy
+12,529
New +$140K ﹤0.01% 12090
2021
Q1
Hold
0
12890
2020
Q4
Hold
0
11746
2020
Q3
Sell
-6,506
Closed -$44K 11216
2020
Q2
$44K Sell
6,506
-558
-8% -$3.65K ﹤0.01% 9783
2020
Q1
$33K Buy
+7,064
New +$61.6K ﹤0.01% 9804
2019
Q2
Sell
-1,538
Closed -$16K 10912
2019
Q1
$16K Buy
+1,538
New +$16.7K ﹤0.01% 8619
2018
Q4
Sell
-2,439
Closed -$58K 10362
2018
Q3
$58K Buy
+2,439
New +$80.4K ﹤0.01% 8802
2018
Q1
Sell
-272
Closed -$34K 10417
2017
Q4
$34K Buy
+272
New +$34.4K ﹤0.01% 9005
2017
Q3
Sell
-529
Closed -$63K 9891
2017
Q2
$63K Buy
529
+106
+25% +$17.7K ﹤0.01% 8839
2017
Q1
$83K Sell
423
-225
-35% -$42.8K ﹤0.01% 8463
2016
Q4
$175K Buy
648
+440
+212% +$143K ﹤0.01% 8759
2016
Q3
$82K Buy
208
+117
+129% +$48.1K ﹤0.01% 8009
2016
Q2
$32K Sell
91
-222
-71% -$159K ﹤0.01% 8315
2016
Q1
$261K Sell
313
-365
-54% -$290K ﹤0.01% 7489
2015
Q4
$710K Sell
678
-2,508
-79% -$2.51M ﹤0.01% 6108
2015
Q3
$2.5M Buy
3,186
+2,206
+225% +$2.26M 0.01% 3847
2015
Q2
$1.29M Buy
980
+752
+330% +$1.21M ﹤0.01% 5654
2015
Q1
$463K Buy
228
+36
+19% +$78.2K ﹤0.01% 7237
2014
Q4
$369K Buy
+192
New +$341K ﹤0.01% 7784

Other funds holding RGLS